“Prostate Cancer Active Surveillance Called 'Untreated Cancer' by Life Insurers, Patient Sa” — what this page in the network covers. Howard Wolinsky, a prostate cancer patient, argues that life insurers unfairly label men on active surveillance as having 'untreated cancer,' leading to coverage denials or higher premiums. Active surveillance is a recognized management strategy for low-risk prostate cancer, involving regular monitoring rather than immediate treatment. Wolinsky, who says he keeps every surveillance appointment, rejects the notion that his condition is untreated.
This issue affects thousands of men who follow medical advice to avoid overtreatment, yet face financial penalties. The discrepancy between medical guidelines and insurance underwriting practices raises concerns about patient access to life insurance and the need for updated policies. As active surveillance becomes more common, insurers may need to reassess risk models to align with current oncology standards. For the complete material, the listing points back to the source inside the network.